30-day FRN

asabaliauskas on DSK3SPTVN1PROD with NOTICES

14866

Federal Register / Vol. 81, No. 53 / Friday, March 18, 2016 / Notices

statements may be limited based on the
number of individuals who register to
make statements and available time. If
registering onsite and reading from
written text, please bring 20 copies of
the statement for distribution and to
supplement the record.
In addition to in-person oral
statements at the meeting, public
statements may be presented by
teleconference line. Directions for
accessing the meeting by teleconference
line will be provided to registered
participants prior to the meeting date.
Responses to this notice are
voluntary. No proprietary, classified,
confidential, or sensitive information
should be included in statements
submitted in response to this notice or
presented during the meeting. This
request for input is for planning
purposes only and is not a solicitation
for applications or an obligation on the
part of the U.S. Government to provide
support for any ideas identified in
response to the request. Please note that
the U.S. Government will not pay for
the preparation of any information
submitted or for its use of that
information.
Background Information on ICCVAM
and NICEATM: ICCVAM is an
interagency committee composed of
representatives from 15 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability and promotes
the scientific validation and regulatory
acceptance of testing methods that both
more accurately assess the safety and
hazards of chemicals and products and
replace, reduce, or refine (enhance
animal well-being and minimize or
prevent pain and distress) animal use.
The ICCVAM Authorization Act of 2000
(42 U.S.C. 285l–3) establishes ICCVAM
as a permanent interagency committee
of the NIEHS and provides the authority
for ICCVAM involvement in activities
relevant to the development of
alternative test methods. ICCVAM acts
to ensure that new and revised test
methods are validated to meet the needs
of Federal agencies, increase the
efficiency and effectiveness of federal
agency test method review, and
optimize utilization of scientific
expertise outside the federal
Government. Additional information
about ICCVAM can be found at http://
ntp.niehs.nih.gov/go/iccvam.
NICEATM administers ICCVAM,
provides scientific and operational
support for ICCVAM-related activities,

VerDate Sep<11>2014

19:50 Mar 17, 2016

Jkt 238001

and conducts and publishes analyses
and evaluations of data from new,
revised, and alternative testing
approaches. NICEATM and ICCVAM
work collaboratively to evaluate new
and improved testing approaches
applicable to the needs of U.S. federal
agencies. NICEATM and ICCVAM
welcome the public nomination of new,
revised, and alternative testing
approaches for validation studies and
technical evaluations. Additional
information about NICEATM can be
found at http://ntp.niehs.nih.gov/go/
niceatm.
Dated: March 14, 2016.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2016–06076 Filed 3–17–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Self-Affirmation
Construct Validity
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Institute, the National Institutes
of Health, has submitted to the Office of
Management and Budget (OMB) a
request for review and approval of the
information collection listed below.
This proposed information collection
was previously published in the Federal
Register on January 14, 2016, Vol. 81
pp. 1985 and allowed 60-days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Cancer Institute,
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: NIH
Desk Officer.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if

SUMMARY:

PO 00000

Frm 00045

Fmt 4703

Sfmt 4703

received within 30 days of the date of
this publication.
To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Rebecca Ferrer, Program
Director, Basic Biobehavioral and
Psychological Sciences Branch,
Behavioral Research Program, Division
of Cancer Control and Population
Sciences, National Cancer Institute,
9609 Medical Center Dr., Rockville, MD
20852 or call non-toll-free number (240)
276–6914 or Email your request,
including your address to:
ferrerra@mail.nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
Proposed Collection: Self-Affirmation
Construct Validity, 0925—NEW,
National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection: This information collection,
seeks to refine a theory about how selfcompetence and values play a role in
defensive responses to health
communications. Although
theoretically-driven research has shown
that self-affirmation—a process by
which individuals reflect on values that
are important to them—can improve
responses to health and cancer
communications, the ‘‘active
ingredient’’ (or mechanisms underlying
effectiveness) of self-affirmations is
unknown. Self-affirmation is a potent
means of augmenting the effectiveness
of threatening health communications.
Individuals tend to be defensive against
information suggesting their behavior
puts them at risk for disease or negative
health. Previous evidence suggests that
self-affirmation may reduce
defensiveness to threatening health
information, increasing openness to the
message and resulting in increased
disease risk perceptions, disease-related
worry, intentions to engage in
preventive behavior, and actual
behavioral change. Understanding the
mechanisms that explain these robust
effects would yield evidence important
for dissemination, including ways to
refine self-affirmation interventions and
make them more potent, which could
change the ways that public health
messages are constructed. This research
can inform NCI scientific priorities and
investments in self-affirmation research.
The results of the information collection
will be used to further develop and
improve self-affirmation theory. These
findings may allow future researchers to
develop and test cancer prevention
interventions.

FOR FURTHER INFORMATION CONTACT:

E:\FR\FM\18MRN1.SGM

18MRN1

14867

Federal Register / Vol. 81, No. 53 / Friday, March 18, 2016 / Notices
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total

estimated annualized burden hours are
717.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden
(in hours)

Total
hour burden

Types of respondents

Screener ............................................
Study .................................................

General Public ..................................
General Public ..................................

10,000
1,100

1
1

1/60
30/60

167
550

Total ...........................................

...........................................................

10,000

11,100

........................

717

Dated: March 7, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.
[FR Doc. 2016–06074 Filed 3–17–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIA.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Aging, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
asabaliauskas on DSK3SPTVN1PROD with NOTICES

Number of
respondents

Form name

Name of Committee: Board of Scientific
Counselors, NIA.
Date: May 24–25, 2016.
Closed: May 24, 2016, 8:00 a.m. to 8:15
a.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor

VerDate Sep<11>2014

19:50 Mar 17, 2016

Jkt 238001

Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Open: May 24, 2016, 8:15 a.m. to 12:15
p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Closed: May 24, 2016, 12:15 p.m. to 1:15
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Open: May 24, 2016, 1:15 p.m. to 3:30 p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Closed: May 24, 2016, 3:30 p.m. to 4:30
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Open: May 24, 2016, 4:30 p.m. to 7:00 p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Closed: May 25, 2016, 8:00 a.m. to 8:15
a.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Open: May 25, 2016, 8:15 a.m. to 12:25
p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.

PO 00000

Frm 00046

Fmt 4703

Sfmt 4703

Closed: May 25, 2016, 12:25 p.m. to 1:25
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Open: May 25, 2016, 1:25 p.m. to 3:00 p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Closed: May 25, 2016, 3:00 p.m. to 4:00
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor
Conference Room, 251 Bayview Boulevard,
Baltimore, MD 21224.
Contact Person: Luigi Ferrucci, Ph.D., MD,
Scientific Director, National Institute on
Aging, 251 Bayview Boulevard, Suite 100,
Room 4C225, Baltimore, MD 21224, 410–
558–8110, LF27Z@NIH.GOV.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: March 15, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–06195 Filed 3–17–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections

E:\FR\FM\18MRN1.SGM

18MRN1